Company / Net Debt per Share
SELLAS Life Sciences Group, Inc. Net Debt per Share History
FY2015-FY2018 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Net Debt per Share
-$20.41
FY2018
5-year range
-
FY2015-FY2018
Trend
-16455.2%
vs FY2017
Sector context
#82 of 82
Health Care
What the data says
Net Debt per Share changed -16455% YoY in FY2018, a notable deviation from the 2-year average annual change of -7689%.
Based on SEC 10-K filings.
-20.41 in FY2018.
Improved from $-0.01 to $-20.41 over the past 3 years.
Health Care sector context is included.
Net Debt per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
Top 0% in Health CareTop 0% of 82This company -$20.41 Sector average $13.70
▼
-249.0% below sector average
Key checks
Key Insights
- In FY2018, net debt per share decreased 16455.2% year-over-year.
- Ranks #82 out of 82 companies in the Health Care sector.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -4.39 (distress zone, below 1.8 threshold)
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Net Debt per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2024 | - | - |
| FY2023 | - | - |
| FY2022 | - | - |
| FY2021 | - | - |
| FY2020 | - | - |
| FY2019 | - | - |
| FY2018 | -$20.41 | -16455.2% |
| FY2017 | $0.12 | - |
| FY2016 | - | - |
| FY2015 | -$0.01 | +91.0% |
As of FY2018 · SEC 10-K · Updated Jun 30, 2026